Navigation Links
Azathioprine Can Soon Revolutionize Eczema Treatment

Azathioprine, an immunosuppressant, meant for use in kidney transplant recipients can be used in treatment of eczema, a skin disorder. The drug was discovered 40 years ago, is still used to prevent the rejection of transplanted kidneys// in renal failure patients.

In around the 1960s, Roy Calne showed that azathioprine prevented the rejection of canine kidney transplants. Following this finding, a combination of azathioprine and corticosteroids were developed, for use in patents with transplanted kidneys.

Atopic eczema is a skin disorder that affects nearly 10-15% of children. Approximately one-third of these children carry the disease symptoms, into adulthood. High doses of topical steroid creams are given. This is however not a very effective form of treatment. The lack of a proper available treatment sparked interest among the researchers, in search of a more effective treatment.

Although, some Dermatologists believed that azathioprine could be useful in eczema treatment, no clinical trials had been initiated so far. Nearly 63 patients with atopic eczema, a most common form of the disease were taken up into a 3- month clinical trial.

All the study participants had undergone a variety of treatments, including radiation therapy with ultraviolet light. Surprisingly, treatment with azathioprine was found to cure the irritating skin condition. Although the drug can have serious side effects such as increased susceptibility to infections, it can be minimized by modulating the drug dosage depending on the ability of the patient to metabolize the drug.

'I'd tried everything so had no hesitation in taking part in the trial. At its worst, I'd been covered from head to toe in eczema sores. It was so painful it stopped me from sleeping at night and it affected what I would wear because I tried to cover it up as much as possible. My eczema disappeared within a couple of months. It was the first time I'd been clear of eczema since I was a child,' remarked Lindsay Dodds, one of the study participants.

This path-breaking research has been conducted by Dr Simon Meggitt, Dermatologist, Newcastle's Royal Victoria Infirmary, in association with Prof Nick Reynolds at Newcastle University. 'This kind of promising development illustrates why we are so dedicated to raising funds for research into eczema and related skin disorders that blight so many people's lives,' said Matthew Patey, British Skin Foundation.


'"/>




Related medicine news :

1. Skin cancer linked to usage of Drug Azathioprine in organ transplants
2. Azathioprine to Treat Eczema?
3. Azathioprine 50mg Pills Recalled By FDA And Roxane Labs
4. Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer
5. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
6. Heart Stem Cells Could Revolutionize Cardiac Disease Therapy
7. Monoclonal Anti-Body To Revolutionize Brain Cancer Treatment
8. Bio-Functional Garments That Could Revolutionize Fashion Industry
9. New Technique Could Revolutionize Melanoma Diagnosis and Treatment
10. Absorption Of Carbon Nanotube Measured In Worms Revolutionize Cancer Research
11. Terahertz Imaging Promises To Revolutionize Breast Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult with ... If so, you may be interested in participating in a research study that focuses ... is to understand more about the relational aspects of adults who have gluten sensitivities ...
(Date:8/19/2017)... Rockville, MD (PRWEB) , ... August 18, 2017 ... ... Food and Drug Administration Reauthorization Act of 2017, legislation that provides for greater ... perceived mild to moderate hearing loss to access OTC hearing aids without being ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the ... there are two sides. There are not two sides to hatred, bigotry, discrimination, and ... and prejudice, and the NPEIV stands against all forms of such hatred and discrimination ...
(Date:8/18/2017)... ... August 19, 2017 , ... Mr. Noppadon Pakprot, Deputy Governor ... Thailand Health and Wellness Tourism Showcase 2017 yesterday, which unveiled the latest “Functional ... Tourism Products and Business at TAT said, “Thailand has long been recognized as ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet ... advocating for active, healthy lifestyles and highlighting the importance of proactive eye and ... impairments and shares the latest innovations in hearing aid technology. , In ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... , Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Joel Saban as president, effective Aug. 7, 2017. ... has decided to pursue other interests and will serve as ... tenure, Paul has served us in multiple leadership roles since ... in Jun. 2015 and has provided decisive, strategic leadership which ...
(Date:8/4/2017)... Aug. 3, 2017  Agragen, LLC, a ... in the biopharmaceutical, nutraceutical, and aquacultural feed sectors, ... its lead drug candidates, AGR131.  This drug is ... from the blood of patients suffering from inflammatory ... bowel disease. ...
Breaking Medicine Technology: